The introduction and adoption of cloud computing and nanopore technology are expected to offer numerous opportunities in the global bioinformatics market.
Companion diagnostics offers a set of tools that facilitates biological and clinical information to the pharmaceutical companies that they have to overcome
Healthcare providers’ compliance for clinical diagnostic services is increasing due to the increasing demand for reducing hospitalization time and hospital readmission rates.
The growing numbers of mergers and acquisitions is a key trend observed in the market. Among the various end-user segments of healthcare CRO, the pharmaceutical and biopharmaceutical companies accounted for the largest share in the global market.